Search

everythinglearnresearchcommunity

for

Search:↓

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Diagnosing and treating PCOS in young people is difficult.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.